TW01001, a novel piperazinedione compound, induces mitotic arrest and autophagy in non-small cell lung cancer A549 cells

Mei Chuan Chen, Chun Han Chen, Yi Nan Liu, Hui Po Wang, Shiow Lin Pan, Che Ming Teng

研究成果: 雜誌貢獻文章同行評審

14 引文 斯高帕斯(Scopus)

摘要

Here, we report that TW01001, a novel piperazinedione compound, could be a new mitotic inhibitor for the treatment of non-small cell lung cancer by the following observations in A549 cells: (1) induction of cells to accumulate at G2/M phase, which ultimately led to cell apoptotic death, (2) accumulation of p53 and inhibition of survival signalings, and (3) induction of p53-independent autophagy. Taken together, our data suggested that TW01001 induces autophagy-p53-signaling pathway to cause mitotic arrest and cell growth inhibition in A549 cells and provides the framework for further development as a novel therapeutic agent for lung cancer treatment.
原文英語
頁(從 - 到)370-378
頁數9
期刊Cancer Letters
336
發行號2
DOIs
出版狀態已發佈 - 八月 19 2013

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

指紋 深入研究「TW01001, a novel piperazinedione compound, induces mitotic arrest and autophagy in non-small cell lung cancer A549 cells」主題。共同形成了獨特的指紋。

引用此